Current through Register Vol. 63, No. 10, October 1, 2024
Section 845-025-7020 - Packaging for Sale to Consumer(1) Containers or packaging for marijuana items and industrial hemp commodities or products must protect the packaged item from contamination and must not impart any toxic or deleterious substance to the packaged item.(2) Marijuana items and industrial hemp commodities or products for ultimate sale to a consumer, patient, or designated primary caregiver, except for usable marijuana, usable hemp, immature marijuana plants, and seeds, must: (a) Be packaged in a container that is resealable and continually child-resistant as certified by a qualified third-party child-resistant package testing firm or placed within an exit package that is resealable and continually child-resistant as certified by a qualified third-party child-resistant package testing firm prior to final sale or transfer to consumer, patient, or designated primary caregiver if the product is a cannabinoid product, cannabinoid concentrate or cannabinoid extract;(b) Not be packaged or labeled in a manner that is attractive to minors; and(c) Be labeled in accordance with OAR 845-025-7000 to 845-025-7190.(3) Packaging may not contain any untruthful or misleading content.(4) Nothing in this rule: (a) Prevents the re-use of packaging that is capable of continuing to be child-resistant, as long as the package is in good working order and maintains its child-resistant properties, and as permitted by rules established by the Commission or the Authority; or(b) Prohibits the Commission or the Authority from imposing additional packaging requirements in their respective rules governing licensees and registrants.(5) A licensee or registrant must provide to the Commission or the Authority upon that agency's request, additional information about the testing that was performed by the qualified third party child-resistant package testing firm in accordance with 16 CFR 1700.(6) Licensees and registrants are prohibited from selling packages, containers or devices intended for intravenous delivery.Or. Admin. Code § 845-025-7020
OLCC 3-2015(Temp), f. 12-3-15, cert. ef. 1-1-16 thru 6-28-16; OLCC 2-2016(Temp), f. & cert. ef. 2-23-16 thru 8-18-16; OLCC 6-2016, f. 6-28-16, cert. ef. 6/29/2016; OLCC 12-2016(Temp), f. & cert. ef. 8-23-16 thru 12-26-16; OLCC 22-2016, f. 12-22-16, cert. ef. 12/27/2016; OLCC 6-2018, amend filed 05/23/2018, effective 6/1/2018; OLCC 21-2021, amend filed 12/30/2021, effective 1/1/2022; OLCC 145-2022, minor correction filed 03/25/2022, effective 3/25/2022; OLCC 202-2022, amend filed 11/21/2022, effective 1/1/2023Statutory/Other Authority: ORS 475C.612
Statutes/Other Implemented: ORS 475C.612, ORS 475C.065, 475C.085 & 475C.093